| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4052209
[patent_doc_number] => 05969147
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Substituted biphenyloxazolines'
[patent_app_type] => 1
[patent_app_number] => 9/191850
[patent_app_country] => US
[patent_app_date] => 1998-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17942
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/969/05969147.pdf
[firstpage_image] =>[orig_patent_app_number] => 191850
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191850 | Substituted biphenyloxazolines | Nov 11, 1998 | Issued |
| 09/076710 | OXAZOLE-ARYL-CARBOXYLIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | May 11, 1998 | Pending |
Array
(
[id] => 3933984
[patent_doc_number] => 05939428
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Alkyl N-›3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamates'
[patent_app_type] => 1
[patent_app_number] => 9/073025
[patent_app_country] => US
[patent_app_date] => 1998-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 357
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939428.pdf
[firstpage_image] =>[orig_patent_app_number] => 073025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/073025 | Alkyl N-›3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamates | May 3, 1998 | Issued |
Array
(
[id] => 3926664
[patent_doc_number] => 05945535
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Method of preparing norbenzomorphanes'
[patent_app_type] => 1
[patent_app_number] => 8/982000
[patent_app_country] => US
[patent_app_date] => 1998-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5959
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945535.pdf
[firstpage_image] =>[orig_patent_app_number] => 982000
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/982000 | Method of preparing norbenzomorphanes | Apr 30, 1998 | Issued |
| 08/952156 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | Apr 5, 1998 | Abandoned |
Array
(
[id] => 3956170
[patent_doc_number] => 05935961
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Pyridazinones and their use as fungicides'
[patent_app_type] => 1
[patent_app_number] => 9/050308
[patent_app_country] => US
[patent_app_date] => 1998-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7828
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935961.pdf
[firstpage_image] =>[orig_patent_app_number] => 050308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/050308 | Pyridazinones and their use as fungicides | Mar 29, 1998 | Issued |
Array
(
[id] => 3949879
[patent_doc_number] => 05955457
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Water soluble rapamycin esters'
[patent_app_type] => 1
[patent_app_number] => 9/046043
[patent_app_country] => US
[patent_app_date] => 1998-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4800
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955457.pdf
[firstpage_image] =>[orig_patent_app_number] => 046043
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/046043 | Water soluble rapamycin esters | Mar 22, 1998 | Issued |
Array
(
[id] => 4048994
[patent_doc_number] => 05968943
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Derivatives of camptothecin and methods of treating cancer using these derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/030357
[patent_app_country] => US
[patent_app_date] => 1998-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 20
[patent_no_of_words] => 12932
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/968/05968943.pdf
[firstpage_image] =>[orig_patent_app_number] => 030357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/030357 | Derivatives of camptothecin and methods of treating cancer using these derivatives | Feb 24, 1998 | Issued |
| 09/015728 | SOLID DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF GALLIUM | Jan 28, 1998 | Issued |
| 09/012665 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | Jan 22, 1998 | Abandoned |
| 90/004882 | SUBSTITUTED BENZOXAZOLES | Jan 4, 1998 | Issued |
Array
(
[id] => 3987579
[patent_doc_number] => 05910497
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => '16-pyrazinyl-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/991456
[patent_app_country] => US
[patent_app_date] => 1997-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25076
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 521
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910497.pdf
[firstpage_image] =>[orig_patent_app_number] => 991456
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/991456 | 16-pyrazinyl-substituted-4-aza-androstane 5-.alpha.-reductase isozyme 1 inhibitors | Dec 15, 1997 | Issued |
Array
(
[id] => 3761688
[patent_doc_number] => 05843954
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Camptothecin derivatives, preparations thereof and antitumor agents'
[patent_app_type] => 1
[patent_app_number] => 8/976398
[patent_app_country] => US
[patent_app_date] => 1997-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14690
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843954.pdf
[firstpage_image] =>[orig_patent_app_number] => 976398
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/976398 | Camptothecin derivatives, preparations thereof and antitumor agents | Nov 20, 1997 | Issued |
Array
(
[id] => 3989040
[patent_doc_number] => 05910588
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-08
[patent_title] => 'Crystal modification of 2,4-diamino-6-hydroxymethylpteridine hydrobromide'
[patent_app_type] => 1
[patent_app_number] => 8/974369
[patent_app_country] => US
[patent_app_date] => 1997-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2531
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/910/05910588.pdf
[firstpage_image] =>[orig_patent_app_number] => 974369
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/974369 | Crystal modification of 2,4-diamino-6-hydroxymethylpteridine hydrobromide | Nov 18, 1997 | Issued |
| 08/945162 | SUBSTITUTED PHENYLOXAZOLIDINONES AND THEIR USE AS ANTIBIOTICS | Oct 20, 1997 | Abandoned |
Array
(
[id] => 4054594
[patent_doc_number] => 05932727
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Process for the preparation of dioxazine compounds'
[patent_app_type] => 1
[patent_app_number] => 8/951689
[patent_app_country] => US
[patent_app_date] => 1997-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932727.pdf
[firstpage_image] =>[orig_patent_app_number] => 951689
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/951689 | Process for the preparation of dioxazine compounds | Oct 15, 1997 | Issued |
Array
(
[id] => 4052431
[patent_doc_number] => 05932588
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Camptothecin compounds with combined topoisomerase I inhibition and DNA alkylation properties'
[patent_app_type] => 1
[patent_app_number] => 8/946701
[patent_app_country] => US
[patent_app_date] => 1997-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9569
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 379
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932588.pdf
[firstpage_image] =>[orig_patent_app_number] => 946701
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/946701 | Camptothecin compounds with combined topoisomerase I inhibition and DNA alkylation properties | Oct 7, 1997 | Issued |
Array
(
[id] => 4036227
[patent_doc_number] => 05856327
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Pyridazinone derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/936600
[patent_app_country] => US
[patent_app_date] => 1997-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7484
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856327.pdf
[firstpage_image] =>[orig_patent_app_number] => 936600
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/936600 | Pyridazinone derivatives | Sep 23, 1997 | Issued |
Array
(
[id] => 3961889
[patent_doc_number] => 05900486
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-04
[patent_title] => 'N-benzylazolium derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/926392
[patent_app_country] => US
[patent_app_date] => 1997-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12455
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/900/05900486.pdf
[firstpage_image] =>[orig_patent_app_number] => 926392
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/926392 | N-benzylazolium derivatives | Sep 8, 1997 | Issued |
Array
(
[id] => 3776732
[patent_doc_number] => 05808102
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Phosphorus bearing taxanes intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/916298
[patent_app_country] => US
[patent_app_date] => 1997-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27360
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/808/05808102.pdf
[firstpage_image] =>[orig_patent_app_number] => 916298
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/916298 | Phosphorus bearing taxanes intermediates | Aug 21, 1997 | Issued |